In a Law360 article penned by partner Tamsen Barrett (Austin), she provides a list of suggestions to keep in mind when a company explores the intersection of formulation science and intellectual property.
Barrett focuses her practice on intellectual property matters which include domestic and foreign patent prosecution, enforcement and strategic development of patent portfolios.
Publication
The US Supreme Court has ruled that a “pure omission” under Item 303 of Securities and Exchange Commission Regulation S–K cannot give rise to a private action for securities fraud under Section 10(b) and Rule 10b-5(b) of the Securities Exchange Act of 1934.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023
